Aqualyx
A clinically proven fat dissolving injection that permanently destroys stubborn fat cells for a more contoured silhouette.
From £100
Learn moreBody Contouring & Fat Dissolving
Desobody
A targeted fat dissolving treatment for the body that reduces localised fat deposits for improved contours.
About This Treatment
What Is Desobody?
Desobody is a specialised injectable fat dissolving treatment designed specifically for body contouring. Using sodium deoxycholate, it effectively breaks down and destroys fat cells in targeted areas, allowing the body to naturally metabolise and eliminate them. It's an excellent non-surgical option for reducing stubborn fat deposits and improving body contours.
Benefits
Why Choose This Treatment
- Targeted body fat reduction
- Non-surgical contouring solution
- Permanent fat cell destruction
- Gradual, natural-looking results
- Treats multiple body areas
- Clinically effective formula
Suitability
Who Is This Treatment For?
- Those with stubborn body fat deposits
- Anyone seeking non-surgical body contouring
- Those looking to refine specific areas
What to Expect
After a consultation, the treatment area is cleaned and the Desobody solution is injected into the targeted fat deposit. The procedure takes approximately 30 minutes. A course of treatments is usually recommended for optimal results.
Downtime & Aftercare
Moderate. Swelling, bruising, and tenderness are expected for 5–14 days. Compression garments may be recommended.
Your Safety Is Our Priority
Desobody is administered by Stacey, a Registered Nurse, following a comprehensive consultation to ensure your safety and suitability.
Pricing
Desobody Prices
| Desobody | from £100 |
|---|
Questions
Desobody FAQ
What areas can Desobody treat?
Common areas include the abdomen, flanks, thighs, upper arms, and back.
Is it permanent?
Yes, destroyed fat cells are permanently removed. A healthy lifestyle helps maintain results.
Interested in Desobody?
Book a free consultation with Stacey to discuss whether this treatment is right for you.
